Gonococcal antimicrobial susceptibility surveillance in Europe, 2016

Surveillance report
Publication series: Gonococcal antimicrobial susceptibility surveillance in Europe
Citation Link

European Centre for Disease Prevention and Control. Gonococcal antimicrobial susceptibility surveillance in Europe, 2016. Stockholm: ECDC; 2018

Copy citation to clipboard

The overall aim of Euro-GASP is to strengthen the surveillance of gonococcal antimicrobial susceptibility in EU/EEA Member States in order to provide quality-assured data to inform gonorrhoea treatment guidelines. This report presents the results from the 2016 gonococcal antimicrobial susceptibility sentinel surveillance.

Read more

Drug-resistance of gonorrhoea in the EU: persistent but stable

Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP).

Related updates on Neisseria gonorrhoeae


Gonorrhoea - Annual Epidemiological Report for 2018

Surveillance report -


Gonococcal antimicrobial susceptibility surveillance in Europe, 2018

Surveillance report -

Peer-Reviewed Publication

The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area

Dec 2019

Peer-Reviewed Publication

HIV among women in the WHO European Region - epidemiological trends and predictors of late diagnosis, 2009-2018

Nov 2019


Response plan to control and manage the threat of multi- and extensively drug-resistant gonorrhoea in Europe

Technical report -